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Five hundred years of the nephrotic
syndrome: 1484-1984
J Stewart Cameron
SUMMARY
The nephrotic syndrome has emerged overseveral centuries as the consequence
ofcontinuedprofuseproteinuria, arising in turn from a variety oflesions affecting
the glomerulus which impair glomerular ability to retain plasma proteins, in
particular, albumin. As a syndrome, it has its own complications and requires its
own management irrespective of the underlying lesions. Dissection of these by
renal biopsy and by clinical investigation reveals a variety ofsystemic diseases
which affect the kidney, but a majority of primary immune-based diseases
appear unique to the glomerulus. Whether the lesion called by Miuller and Munk
'nephrosis', and now called minimal change disease and focal segmental
glomerulosclerosis is one disease or many, is the subject ofintense debate at the
moment, as is the relationship between two types oflesion. Only a better under-
standing of their pathogenesis, and of how the glomerulus normally retains
plasma protein, will solve this knotty problem.
Although dropsy (oedema) in adults has been known from classical times (for
example, to Hippocrates1), the distinction between the various causes ofoedema
in these early texts - nutritional disturbances, cardiac failure, liver and
gastrointestinal disease as well as renal disease - is not possible to define. One
sage observation made by Hippocrates about the nephrotic syndrome, however,
is familiar to many patients and doctors - that 'when bubbles settle on the
surface ofthe urine, it indicates disease ofthe kidneys and that the complaint will
be protracted'.' This effect of albuminuria on the surface tension of urine may
even be the presenting complaint of some patients, and the date of onset of
profuse proteinuria can usually be determined by direct questioning.
However, in children the causes of severe oedema are a little less complicated,
and thus I take as the start of studies of the nephrotic syndrome itself the book
Liber de aegritudinibus infantium2 (Fig 1) published about 1484 by Cornelius
Roelans (or Roelants) of Mecheln in Belgium (1450-1525). He describes 52
diseases of children, of which the fifty-first is 'swelling of the whole body of the
child'. It seems almost certain that he is describing nephrotic oedema here, but
theshort chapteris mainly devoted to a confused account, based on the Galenical
theories of humours, of how the swellings might arise; the kidneys are nowhere
mentioned. At the end, however, he states: 'Then the child may be cured by a
remedy that I found in a certain pamphlet on diseases of children. Take the tops
of the elder plant, and danewort, cook in white wine and wrap the child in hot
cloths by applying a poultice in whole or in part, and so cure him'. Perhaps a
prospective controlled trial is needed here! Roelans also gives homely advice on
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Fig. 1
The page in Cornelius Roelans'
De aegritudinibus infantium of
1484 which contains perhaps the
earliest description of a nephrotic
child: 'The fifty-first disease of
children is swelling of the whole
body of the child'. Reproduced
from reference 2.
less abstruse problems of childhood such as teething pains (treat with honey and
butter on the gums of the child).
We now leap forward almost 250 years, to a really remarkable early description
of the nephrotic syndrome by Theodore Zwinger III of Basel (1658-1724) in his
Paedoiatreia practica of 1722.3 This text is known to some historians of
paediatrics,4 but has been completely ignored by nephrologists. His description of
the physical signs of the nephrotic syndrome in chapter 1 19 is quite remarkable,
and is worth quoting in full: 'Oedema, generally called hydrops, is a condition
involving swelling of the whole body. From head to foot the skin is a pale dirty
yellow, the swelling is oedematous and characterised by inflation of the whole
periphery with persistent collections of lymph. The swelling is not hard or tense,
but such that the print of a finger remains behind. Commonly, thirst is very great,
the bowel action not as free as usual, and the urine is scanty because of
obstruction and compression of the tubules of the kidney. The breathing is
difficult, often accompanied by anxiety because of the compromised function of
chest muscles and diaphragm from the swelling of the skin. Besides, there is a
continued fever, and soon a strong desire to sleep appears because the brain is
overfull withserum; sleepispoorbecauseofdisturbanceofthe"spiritus animalis".
Additionally, there may be a dry cough from irritation ofthe nerves to the lung by
the liquid, salty lymph. At the beginning, the swelling may be small, but later it
increases steadily ifthe remedies used do not have their expected effects, so that
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legs, abdomen and even the face are blown up with a bluish colour, and one must
fear attacks of suffocation. We have seen children of either sex in whom the
eyelids were so swollen they could not open their eyes, and also the genitalia
were so swollen and full of serum, that they looked almost transparent. In boys,
the virile member was so swollen that they could make water only with difficulty'.
Thus in 1722, more than 100 years before Bright, Zwinger described the
nephrotic syndrome and placed the seat ofthe disease firmly in the kidneys! This
is all the more remarkable, because at this time Morgagni had of course not
published his great classic De sedibus et causis morborum,5 which established
the idea that diseases might arise from specific organs. Incidentally, in this latter
work one can find one of the first descriptions ofthe pale, mottled kidneys of the
nephrotic patient.
Zwinger did not, however, perform any tests on the urine that we know of, and it
was only after proteinuria had been described for the first time in conjunction with
oedema by Domenico Cotugno (1736-1820) in his De ischiade nervosa
commentarius of 1770, that Richard Bright (1789-1858) and others could put
together the triad of proteinuria, diseased kidneys and oedema. Despite the fact
that other observers in Britain, notably William Wells ofStThomas' Hospital7 and
John Blackall of Exeter,8 came close, Bright's claim to having described the
nephrotic syndrome in all its detail in his classic Reports of medical cases of
18279 must be sustained, in conjunction with the chemical observations of his
lesser-known colleague, John Bostock (1773-1846), chemist and physician of
Liverpool. Bostock 10 quantified the urine and serum proteins by methods
depending upon specific gravity, noting that the greater the amount in the urine,
the less in the blood. This observation was confirmed in 1829 by Robert (laterSir
Robert) Christison of Edinburgh (1797-1882),'1 who stated: 'The specific gravity
of the serum has always been lowest where the urine was loaded with albumin. It
is hence probable that the albuminous secretion ofthe urine is nothing more than
a transudation of serum from the blood'.
Thus, by 1830 the nephrotic syndrome of profuse albuminuria, hypoalbumin-
aemia and oedema resulting from diseased kidneys leaking protein into the urine
was established.
One of the many tasks to which these early workers addressed themselves (and
which remains uncompleted to this day) was to establish how the oedema came
about. The usual explanation is given in Fig 2, which presupposesthat, during the
active formation of oedema at least, the circulating plasma volume will be low,
and that what are usually called Starling forces will operate less avidly than usual
because of lowered oncotic pressure in the plasma. This theory was, however,
suggested by a certain J-C Sabatier in Paris as early as 1834:12 'The serum ofthe
blood being depleted (of albumin) becomes more fluid, thinner and by this it is
able more easily to penetrate the walls ofthe arterial capillaries. If it is possible to
suppose that, following this modification of the blood, venous absorption is less
active, one can see how in such cases the effusions in the serous cavities and
infiltrations of the tissue may arise'.
The problem of how nephrotic oedema accumulates is still not settled,13 and
Dorhout Mees and his colleagues have repeatedly emphasised their own13.15 and
earlier observations16 17 that the plasma volume in stable, untreated adult
nephrotics is usually normal, or even increased. In contrast, many paediatricians
(and rather fewer internists) including ourselves have seen untreated patientswith
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Fig. 2
The usual explanation for the
accumulation of nephrotic oedema,
which presupposes a reduced
plasma volume at least in the phase
of active oedema formation (See
text).
a nephrotic syndrome, usually with minimal change disease, arrive at hospital
alreadyinshockoreveninestablished acute renal failure. Melzerand colleagues18
pointed out that patients with minimal change disease (who form the great
majority of patients with a nephrotic syndrome in childhood) usually have high
plasma renins, whilst the levels in most other nephrotic patients are normal.
Thus, itdoesseempossibletoreconcilethesedisparate observations. Immediately
after proteinuria begins, or reaches nephrotic proportions, the plasma albumin
falls as a result of both excretion and increased renal catabolism of reabsorbed
albumin. The plasma volume contracts, triggering humoral and physical stimuli
tothe renal tubules which result in more avid retention ofsodium, and secondarily
of water. Excretion of a water load in nephrotics is reduced in most studies19 and
occasionally true hyponatraemia may be seen as opposed to 'false' or 'dilutional'
hyponatraemia dependent on high lipid levels. This retained salt and water is
distributed more into the tissues than normally because of the lowered plasma
oncotic pressure, but gradually the plasma volume is restored to normal - at the
price of an expanded extracellular space, a great increase in total body sodium
(which can more than double) and visible oedema. Thus the patient 'purchases' a
normal plasma volume in the face of hypoalbuminaemia; but the price is
oedema. Equally, if the doctor gives diuretics he will eliminate thia oedema, but
the 'price' will be hypovolaemia.
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TABLE I
Complications ofthe nephrotic syndrome
Common: Infections . . * peritonitis} ±septicaemia
Thrombosis . venous ± embolism
arterial
Hypovolaemia . circulatory collapse
( + diuretics) acute renal failure
Hyperlipidemia . . . ? accelerated atherogenesis
Protein depletion . . . osteoporosis + stones
striae
wasting
Uncommon: Fanconi syndrome*
Fe deficiency anaemia
*particularly in patients with focal segmental glomerulosclerosis.
One of the complications (Table I) from which nephrotic patients may suffer is
acute renal failure. The cause of this acute renal failure principally seen in
nephrotics with minimal change and focal sclerosing lesions,20 25 is not known.
Diagnosis may be difficult if the patient presents in this state, since the urine will
contain not only large amounts of protein but also red and white cell casts and
many red blood cells, presumably the result of associated tubular necrosis. Thus,
the appearances exactly mimic those of an acute proliferative glomerulonephritis,
with or without crescents, and early renal biopsy is necessary to make the
diagnosis (see below). To begin with, this complication of acute renal failure was
thought always to be associated with hypovolaemic shock and circulatory
collapse,21 and there is little doubt that this accounts for some cases, often
accompanied by septicaemia (see below). Another group of nephrotic patients
who go into acute renal failure have been given large doses of contrast media, or
non-steroidal anti-inflammatory agents,22, 23 both of which are known to be
nephrotoxic. The latter group is of particular interest since the agents (especially
fenoprofen) seem able to induce a minimal change nephrotic syndrome, with or
without an infiltrate, mainly of T-helper cells, in the interstitium.24 Finally, and
most puzzling, is a group ofpatients who present in acute renal failure without any
antecedent circumstances except growing oedema, without any signs of
hypovolaemia, and who have minimal changes in their renal biopsy.25 These
patients tend to be olderthan 50 and relatively resistant to treatment with cortico-
steroids; they sometimes do not recover renal function and may succumb
because of nutritional and other problems associated with persisting torrential
proteinuria - despite their oliguria - together with uraemia. We have seen four
such patients, of whom only one survived. Lowenstein and others26 have
suggested that a factor in acute renal failure in these nephrotics may be increased
renal interstitial pressure from oedema, but no measurements have been made to
support or deny this hypothesis.
Another complication that nephrotic patients may suffer is thrombosis. It seems
strange that Bright and his colleagues, with their large experience of nephrotic
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patients, do not comment on this aspect. This is all the more surprising when we
realize that many of their patients (including Mary Sallaway, whose case is
described in the Reports ofmedical cases, and whose kidney is still in the Gordon
Museum at Guy's Hospital) suffered from amyloidosis;28 we know now that such
patients are particularly prone to develop renal venous thrombosis.29 However,
the first descriptions of renal venous thrombosis came from Osborne in Dublin,30
who made little of the association, which he found by chance at post mortem in a
nephrotic middle-aged man without specific symptoms. The first detailed
description of renal venous thrombosis was by Bright's great Parisian
contemporary, Pierre Rayer (1793-1862), in his encyclopaedic book and atlas
on diseases of the kidney, published in 1840.31 In this he described two cases of
renal venous thrombosis in nephrotics: one being of a young prostitute who had
acute loin pain and fever in association with the thrombosis.
There is much controversy about the incidence of renal venous thrombosis in
nephrotic patients.27 32.36 The only point above contention is that it is much
commoner in nephrotic patients with membranous nephropathy, an association
which remains unexplained; presumably some as yet unstudied aspect of
coagulation is more abnormal in such patients (see below). Several authors3234
have shown that, by careful angiography, up to as many as 40% of nephrotic
patients with membranous nephropathy may have small, silent renal venous
thrombi, and a lower, but still substantial proportion of patients with other forms
of glomerular disease underlying their nephrotic syndrome are similarly affected.
However, my associates and 1, in common with other workers,35 have been
unable to confirm these findings, only 5*10% showing thrombosis. It may be that
there are real geographical variations in the incidence of renal venous thrombosis
in membranous nephropathy, and hence in the nephrotic syndrome as a whole.
What is not clear either is what should be done about symptomless venous
thrombosis if it is found. No prospective study has dealt with the question of what
happens in such patients who are not anticoagulated (as must happen to their
symptomless counterparts who do not have angiography), and are thus never
diagnosed. It is clear that, in the presence of anticoagulation, symptomless renal
venous thrombosis is benign, neither renal functional deterioration nor increase
in proteinuria being associated with its presence, either at the time of
diagnosis31 32 or later. Unfortunately, neither ultrasound nor CAT scanning
seems able to equal the performance of invasive angiography in making the
diagnosis, a procedure not without risk. Thus, few clinicians perform venography
in all their nephrotic patients unless symptoms indicate;36 but many will perform
it routinely, or have a lower clinical threshold for performance, in nephrotic
patients with membranous nephropathy.
Thrombosis as a whole is a danger which stalks the nephrotic patient, and
remains a worrying source of morbidity and mortality. What makes it of particular
note is that diuretic treatment, presumably by raising the haematocrit and
increasing blood viscosity,37 38 may increase the chances of thrombosis. It has
been a cause of death in our own series of adult77 and childhood49 nephrotics,
and in a recent series of nephrotic children.39 However, the pattern of thrombosis
is different in adults and children.27 One large survey of European centres27 40
found that almost half the children had arterial thrombosis, whereas in the adults
the great majority had venous thromboses, although arterial thromboses are also
seen.27 In children, the arterial thromboses affected almost any artery in the
body, intracardiac and pulmonary artery thrombosis being remarkably
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common27 40 and aortic thrombosis recorded.27 It is worth noting that the only
other group of children who suffer similar major vessel thromboses are those with
congenital cyanotic heart disease with high haematocrits. Venous thrombosis is
remarkably common in nephrotics. At a clinical level in our own series, 11 of 89
adult-onset minimal change patients had deep venous thromboses, associated
with obvious pulmonary emboli in seven, whilst only one had an arterial
thrombosis (femoral). Doppler ultrasonography, however, reveals that as many
as one quarter of adult nephrotics have thrombi in their deep calf veins.41
Similarly with pulmonary embolism: less than 5% of adult nephrotics overall will
have clinically evident emboli, but ventilation/perfusion isotope scanning reveals
that about 15% have evidence of pulmonary emboli.27 42 This complication is
rare, however, in nephrotic children, as it is in children as a whole. Renal venous
thrombosis, whether symptomless or evident. is associated with a high incidence
of emboli, averaging about one third of cases in 11 published series.27
Why do nephrotic patients show this extraordinary tendency to thrombosis?
(Table 11). There are many abnormalities of circulating haemostatic proteins,27
both procoagulant and regulator, in the nephrotic syndrome.27 In general, those
of low molecular weight are lost into the urine in excess of synthesis, and so the
plasma concentrations fall (factor IX, X, Xi, XIl, prothrombin, plasminogen,
antiplasmin, antithrombin III, protein C, a, antitrypsin); whilst, in those of high
molecular weight, synthesis exceeds losses, with a rise in plasma concentrations
(Factor VIII/von Willebrand factor, fibrinogen, factor V, factor VIl, a2macro-
globulin). It is difficult to judge what effect all these alterations will make in an
individual case. There is already present in the plasma a manifold excess of such
factors as VIII, V and VII, and whether further increases produce a prethrombotic
state is doubtful. Although antithrombins are lost into the urine (antithrombin 111,
a, antitrypsin) ag2macroglobulin rises, so that the total antithrombin activity is
normal or even raised in most nephrotics. Inhibitors ofplasmin are essentially the
same serine protease inhibitors, with the addition of a2 antiplasmin, which protein
accounts for much of the in vivo activity; this is usually reduced in nephrotic
patients. Recently, however, Pollak and his associates43 have implicated both
inhibitors of plasminogen activation and antiplasmin in the genesis ofthrombosis
in nephrotic patients, particularly renal venous thrombosis in those with
menbranous nephropathy.
TABLE II
Factors involved in the thrombotic tendency ofnephrotic patients
Humoral Raised factors 1, V, VII, Vill
Raised plasma lipids
Platelets Hyperaggregability - ? arachidonatelt
Fibrinolysis Reduced plasminogen
Antiplasmins
Loss of antithrombins in urine
Mechanical Immobility
Repeated vascular punctures
Haemoconcentration - viscosity raised
latrogenic Corticosteroids
Diuretics - worse hypovolaemia
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However, it may be that abnormalities of platelet function account for much of the
thrombotic tendency in nephrotics.44 When plasma albumin is reduced, the
numberof binding sites competing with the platelet cycloxygenase forarachidonic
acid is reduced. Thus, more arachidonate is available for thromboxane A2
synthesis by the platelets, which increases, and ex vivo platelets will aggregate
supranormally to arachidonate, ADP or collagen, a phenomenon which can be
corrected both in vivo and ex vivo by the addition of albumin.44 Clinically, the
nephrotics at risk of thrombosis are those with a severe reduction in serum
albumin to below 20 g/1,42,44 and it may be that this hyperaggregability operates
through this mechanism. However, our own recent unpublished observations that
nephrotic platelets are hyperaggregable to ristocetin, which does not require
arachidonate or thromboxane A2, suggests that this is not the whole story.
The most common complication of the nephrotic syndrome in former times was
however infection, which, until the antibiotic era, resulted in early death in the
majority of nephrotic children4547 and a considerable number of adults.48 Even in
the present era replete with antibiotics, sepsis is still a problem, accounting for
deaths in our own series of children,49 as well as those of the International
Study.39 The peculiar susceptibility of nephrotic children to infections with
encapsulated organisms, in particular Strep. pneumoniae, has been noted for
many years. This infection seems never to occur in adults, our oldest patient with
pneumococcal peritonitis being 21 years of age. It is probable that this peculiar
susceptibility is associated with losses of alternative pathway components of the
complement system in the urine,50 although why adults should be protected is
not known. Primary peritonitis, usually with septicaemia, is of course the
commonest presentation, and a recent analysis of peritonitis shows,51 as in our
own experience, that in children it is still a problem. In Krensky's review of
peritonitis over the period 1970-1980,51 24 episodes of peritonitis occurred in
19 of 351 nephrotic children: 50% were from Strep. pneumoniae, and 25%
from E. coli.
Another major problem which was a cause of death until the antibiotic era was
cellulitis. This can spread with terrifying rapidity in the oedematous tissues of the
nephrotic patient, and may arise from splits in the skin occasioned by the
swelling. The organism is usually present in the blood stream and can more
usually be obtained from the blood than from the local lesion.
The final complication of the nephrotic syndrome that I wish to deal with was
heralded by John Blackall in 1811,8 who noted that the serum of blood drawn
from nephrotic patients was milky in appearance; an observation which may well
have been made earlier in dropsy, given the popularity of blood-letting in the
eighteenth century. Twenty-five years later, Robert Christison established by its
solubility in sulphuric ether that this material was indeed fat.59 We now know53
that there are complex alterations of lipoproteins in nephrotic patients, with rises
in VLDL and LDL cholesterol fractions, although in most patients HDL is normal,
being low only in an occasional patient with relentless proteinuria and very low
serum albumin; of the subfractions, HDL2 is selectively reduced. In all cases with
or without visually evident hypertriglyceridaemia, the total cholesterol is very
much elevated in proportion to the reduction in plasma albumin. The reasons for
the increased hepatic synthesis of apoprotein, which is responsible, along with
urinary losses, for these changes, are poorly understood. Naturally these changes
in circulating lipids lead to speculation as to whether nephrotic patients are more
susceptible to vascular disease, and in particular myocardial infarction, since
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similar changesinthe blood fatsofcontrol populationsare knownto beassociated
with increased mortality from vascular causes. It has proved surprisingly difficult
to give an answer to this apparently simple question.54 55 From the beginning, it
seemed that childrenand young adultswith anephroticsyndrome and precocious
atheroma suffered from relentless nephrotic syndromes, and a number had what
we would now recognise as focal segmental glomerulosclerosis (FSGS)
lesions.46'56,57 In fact, it emerges from follow-up studies58 that rather few other
patients remain nephrotic for long periods of time - only one-third had a
nephrotic syndrome for more than four years in our study. The remainder either
lose filtering surface and go into renal failure, with diminishing proteinuria, or
remit spontaneously or in response to treatment. It is noticeable that in
progressive FSGS with renal failure, profuse proteinuria may persist right into
terminal renal failure and even require nephrectomy. Thus, only a tiny proportion
of nephrotics are subjected to continuous hyperlipidaemia over many years.
Finally, many ofthese patients have underlying glomerular disorderscomplicated
by hypertension, itself a powerful risk factor in the genesis of vascular damage.
Thus the question is not a simple one. Anecdotally, there is no doubt that some
nephrotics suffer thrombosis of their coronary arteries,59-61 and it is tempting to
attribute this as a complication of their nephrotic state as one would any other
thrombosis, or as a result ofthe lipid alterations. Because ofsmall numbers, it has
not proved possible to study individual subgroups particularly at risk (forexample
patients with focal segmental glomerulosclerosis) but overall our large nephrotic
population in the South-East of England did not show a mortality significantly in
excess of a carefully-matched local control population.58 Other papers on the
subject have not made similar comparisons with appropriate controls.59 61
Until 1950, our knowledge-of the underlying histopathology of the kidney in
nephrotic patients was based on those unfortunates coming to post mortem
either through renal failure, orthrough some complication ofthe condition.45-4862
It was known well before 1900 that a nephrotic syndrome could complicate
diabetes, syphilis,8 treatment with mercury,8 30 amyloidosis,63 and last of all
Schonlein-Henoch purpura64 and systemic lupus.65 It had been known even
earlier that a nephrotic state might complicate post-scarlatinal nephritis,66 and
thus some idea of'secondary' and 'primary' nephrotic syndromes was established
quite early. However, the histology of these 'primary' nephrotic syndromes
continued to puzzle workers in the field from 1900 onwards. In general, they
could see few changes using the optical microscopy of the period in many of
these nephrotics dying of complications, including those suffering from syphilis.
Friedrich von MUller of Marburg (1858-1941) made his major (and dubious)
contribution to nephrology in 190567 by introducing the term 'nephrosis' as an
antithesis to 'nephritis', implying a 'degenerative' lesion of the kidney rather than
an 'inflammatory' one; this term was popularized by Fritz Munk (1879-1945)68
who mainly studied syphilitic nephrotic syndromes. The techniques of the period
could not distinguish the early changes of membranous nephropathy, almost
certainly present in these patients, from normality; and it was not until 1932 that
ET Bell,69 using newer stains, described severe membranous nephropathy.
Workers of the period were unable to accept the possibility of a functional defect
in the glomerulus without changes visible on optical microscopy, and thus the
idea of 'pure nephrosis' (minimal change disease, as it would now be called) as a
tubular lesion became current. About the same time, Henry Christian48 and Louis
Leiter45 in the United States pointed out the similarities ofprimary and secondary
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forms of severe proteinuric disease with oedema, and introduced the terms
'syndrome of nephrosis', or 'nephrotic syndrome', to emphasise the relationship,
which gradually achieved popularity.70
We recognise now, following the introduction of percutaneous needle renal
biopsy to the study of glomerular disease in the early 1950s by Poul Iverson and
Claus Brun in Denmark,7' and Robert Kark and Bob Muehrcke (then a medical
student) in the United States,72 that as well as the many different clinical
circumstances associated with the nephrotic syndrome, a variety of different
types of histopathology may underly it,73 74 thus making the dissection by the
technique of needle biopsy a major feature ofthe management, at least in adults.
The pattern of underlying histopathology for an unselected British population of
nephrotics is shown in Fig 3. This is based on a personal series of more than 500
patients with onset over the age of 15, and for 200 children biopsied up to 1970,
when we ceased to biopsy every nephrotic child.
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Fig. 3. The underlying glomerular histological appearances found in a series of over 700 nephrotic
children and adults seen at Guy's Hospital 1963-1984. The 506 adult biopsies were taken during the
whole of this period; the 200 children were all biopsied before 1970, at a time when (as is still our
policy in adult nephrotics) all children with a nephrotic syndrome were subjected to renal biopsy.
(HSP = Henoch-Sch6nlein purpura; FSGS = focal segmental glomerulosclerosis; MCGN = mesangio-
capillary glomerulonephritis; 'other proliferative' includes predominantly crescentic (extracapillary)
forms, IgA- and IgM-associated nephropathy and other mesangial proliferative glomerulonephritides,
and focal proliferative glomerulonephritis. 'Others' includes all other forms of glomerular disease not
included in the above categories, e.g. the congenital (Finnish) nephrotic syndrome in infants, micro-
scopic polyarteritis and paraproteinaemia in adults, etc.)
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The reasons for this decision are evident in the diagram: underthe age of 6 or so,
the overwhelming number of children show the minimal change lesions of 'lipoid
nephrosis' and almost all are responsive to corticosteroids, losing their proteinuria
within at most 4 weeks' treatment. A further 25% of those with focal segmental
glomerulosclerosis will also lose proteinuria. Thus, it isjustified to give almost all
young nephrotic children corticosteroids, provided their urine does not contain
persistent haematuria with casts. Then in the minority, with no response by at
most 4 weeks, a biopsy can be done at this point.
Recently, it has been suggested that a similar policy be adopted for adult
nephrotic patients,75 76 on the groundsthat the extra information gained from this
invasive procedure does not justify the risk. The calculations used involve some
rather uncertain data or assumptions, but the idea falls down on two other
accounts. First, how long in an adult with minimal change disease must corti-
costeroids be given to achieve a good chance of remission? An analysis of our
own adult series of patients with minimal change nephrotic syndrome, shortly to
be published,77 shows that adults take much longer to respond to steroids than
children: treatment for at least 16 weeks, not 4 weeks, would be necessary to
identify the non-responders - who would be some 70% of the total, not 10%.
The risks of a longer course such as this to the majority who would not benefit
almost certainly exceeds the dangers of renal biopsy, especially in older patients.
That this difference between adults and children is not simply the result of using
relatively lower doses of corticosteroids in the adults is suggested by the
observation that their response to an identical dose of cyclophosphamide on a
bodyweight basis (3 mg/kg/ideal weight for height for 8 weeks) is similarly
retarded.
Also, there are very few clinical pointers which will indicate either an early
response to treatment with corticosteroids, or a good prognosis in the long run
(Table 111). Surprisingly, renal function at presentation is little or no guide to the
degree of underlying irreversible renal damage, since the haemodynamic events
of the nephrotic syndrome override the effects of the underlying type of
glomerular disease. Obviously the age at onset, as indicated in Figure 3, gives
some clue as to what the likely cause may be. Hypertension also is of little help in
TABLE III
Prognostic factors in the nephrotic syndrome
Observation Effect on prognosis
At onset:
Persistent haematuria Often bad
Hypertension Sometimes bad
Diminished renal function Useless
Persistent hypocomplementaemia Usually bad
During subsequent course:
Loss of proteinuria to corticosteroids Good
Spontaneous remission of proteinuria Good
Failure to lose proteinuria on steroids Sometimes bad
Persisting nephrotic syndrome > 2 years Usually bad
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adults with nephrotic syndromes; patients with minimal change disease are
hypertensive surprisingly often at onset,13-15 which remits with the proteinuria;
and we have made the same observations in some childhood nephrotics;
presumably this is the result of volume contraction and renin secretion. A low
serum complement is of use principally because of its association with mesangio-
capillary glomerulonephritis (MCGN), which in general has a poor prognosis.
However, above all, it is those nephrotics with persistent microscopic haematuria
as well asprofuse proteinuria who in general do badly, since this is a characteristic
of most of the progressive forms of glomerular damage. In the longer term,
persistence ofthe proteinuria at nephrotic levels is a poor prognostic sign. Long-
term studies in our unit show that, in most patients who will ultimately heal, the
proteinuria rarely remains in the nephrotic range more than a year or two.
Conversely, the serum creatinine is almost always raised permanently in those
with progressive disease after only 2.4 years of evolution. Essentially all patients
who lose their proteinuria maintain their renal function, unless hypertension has
developed and is inadequately treated.
Another interesting observation we have made recently49'77,78 is that the
frequency and rate of relapses in minimal change nephritis patients declines
steadily with increasing age at onset of the disease. In children. all those who ran
very long-term relapsing courses had an onset less than six years of age, and the
average number of relapses declined steadily from 1 *15 years of age. Amongst
adults, the same gradient with age is evident: although as high a proportion of
adults have at least one relapse as in childhood (about 70%), overall the total
number of relapses is much less; that is, fewer adults become frequent relapsers.
This is particularly noticeable in the older patients: over 60 years of age, relapses
are rare, although the initial nephrotic episode in these old patients may be
devastating and some may die in the acute phase.
For a much more extended account of the history ofthe nephrotic syndrome, the reader is referred to
Chapters 1 and 2, by JS Cameron and RJ Glassock, and RM Kark respectively, in the forthcoming
book The nephrotic syndrome, edited by JS Cameron and RJ Glassock (New York: Marcel Dekker),
now in preparation.
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